BIOTRANSPLANT AND METHOD FOR TREATING CHRONIC CARDIAC FAILURE (VARIANTS) Russian patent published in 2007 - IPC A61K35/48 A61P9/04 

FIELD: biopharmacology, medicine.

SUBSTANCE: the suggested biotransplant contains mesenchymal stem cells, myoblasts, endothelial precursor cells. The sources for obtaining the cultures being the constituents of biotransplant should be obtained both out of fetal and donor material including the obtaining of autologous cultures; as for biotransplant's variant, it contains myoblasts out of human skeletal fetuses and a biotransplant that contains endothelial precursors; the innovation refers to the method for obtaining biotransplant out of skeletal muscles tissue, and the method for treating chronic cardiac failure. Cellular therapy at different cardiovascular diseases should be usefully applied in a monovariant and in combination with conventional surgical therapeutic methods. The innovation increases the efficiency of impact upon human myocardium.

EFFECT: higher efficiency.

12 cl, 1 ex